サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654731

フィトエストロゲンサプリメントの世界市場：2025年～2033年

Global Phytoestrogen Supplements Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
フィトエストロゲンサプリメントの世界市場：2025年～2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フィトエストロゲンサプリメントの世界市場は、2024年には357万米ドルに達し、2033年までには511万米ドルに達すると予測され、予測期間中の2025年から2033年にはCAGR4.6%で成長すると予測されています。

世界のフィトエストロゲンサプリメント市場は、体内でエストロゲンを模倣する植物由来の化合物であるフィトエストロゲンを含む栄養補助食品市場を包括しています。これらのサプリメントは主に、特に更年期のホルモン変化に関連する症状を緩和し、女性の健康全般をサポートするために使用されます。

世界のフィトエストロゲンサプリメント市場は、女性の健康問題に対する消費者の意識の高まりと、更年期障害に関連する症状に対する自然療法への需要により、大きく拡大する見通しです。様々な用途に利用可能な多様な製品群により、この市場は、健康志向の消費者への対応を目指すメーカーやサプライヤーに多くの機会を提供しています。これらの要因が、世界のフィトエストロゲンサプリメント市場拡大の原動力となっています。

市場力学：

促進要因と抑制要因

ホルモン補充療法（HRT）に代わる自然療法への需要の高まり

ホルモン補充療法（HRT）の天然代替品への需要の増加は、フィトエストロゲンサプリメント世界市場の重要な促進要因です。この動向は、消費者、特に更年期を経験する女性の間で、ホルモンの変化や関連症状を管理するためにより安全で自然な選択肢を求める傾向が強まっていることを反映しています。

従来のホルモン補充療法は、ほてりや気分の落ち込みといった更年期症状の緩和に有効でした。しかし、ホルモン補充療法は、乳がん、心臓病、血栓のリスク上昇など、潜在的な健康リスクと関連していることが多いです。こうしたリスクに対する認識が高まるにつれ、多くの女性が、関連する危険性を伴わずに同様の利点をもたらす代替品を求めています。

社会全体が自然でホリスティックな健康法へとシフトしています。消費者は、より安全で健康的なライフスタイルに合致していると認識される、植物などの天然源に由来する栄養補助食品への関心を高めています。大豆、亜麻仁、レンズ豆など様々な植物性食品に含まれるフィトエストロゲンは、合成ホルモンに代わる植物由来の代替品を提供します。

さらに、業界の主要企業は、世界のフィトエストロゲンサプリメント市場の拡大を促進するであろう投資や研究開発を行います。例えば、2023年10月、ツーソンに拠点を置く新興企業NeuTherapeuticsは、米国立衛生研究所（NIH）、特に米国立老化研究所（NIA）から250万米ドルの助成金を獲得しました。この助成金は、更年期女性のほてり緩和を目的とした栄養補助食品PhytoSERMの有効性評価を目的とした第2相臨床試験を支援するものです。これらすべての要因が、世界のフィトエストロゲンサプリメント市場に需要をもたらしています。

また、2023年12月には、選択的エストロゲンB受容体フィトエストロゲン製剤であるPhytoSERMの開発により、アルツハイマー病のリスク低減と更年期症状の緩和という、女性にとって重要な2つの健康問題に取り組むことを目指しています。この取り組みは現在、第2相ランダム化臨床試験の枠組みで検討されています。さらに、機能性食品・飲料のモニタリングにおける成長需要の高まりが、世界のフィトエストロゲンサプリメント市場の拡大に寄与しています。

副作用のリスク

フィトエストロゲンサプリメントに関連する副作用のリスクは、フィトエストロゲンサプリメントの世界市場において重要な制約となっています。フィトエストロゲンは、ホルモン補充療法（HRT）の自然な代替品として人気が高まっているにもかかわらず、安全性や潜在的な副作用に関する懸念が消費者の信頼を損ない、市場の成長を妨げる可能性があります。このような副作用は、消費者が一貫してこれらの製品を使用する意欲を失わせ、市場拡大を制限する可能性があります。

メタ分析によると、フィトエストロゲンサプリメントは、腹部不快感や吐き気などの消化器系の副作用の発生率が中程度に高いことが示されています。このような問題により、使用を中止する人もいるため、消化器系の健康を心配する潜在的なユーザーにはためらいが生じます。このように、上記の要因がフィトエストロゲンサプリメントの世界市場の潜在的成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ホルモン補充療法（HRT）の自然な代替品に対する需要の増加
    • 抑制要因
      • 副作用のリスク
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 タイプ別

  • フラボノイド
    • ダイゼイン
    • ゲニステイン
    • グリシテイン
    • ビオカニンA
    • クメスタン
    • プレニルフラボノイド
  • リグナン
  • スチルベン
  • その他

第7章 ソース別

  • 大豆エキス
  • ナッツ類・油糧種子
  • シリアル・パン
  • 豆類
  • その他

第8章 用途別

  • 食品・飲料
  • 栄養補助食品
  • 化粧品
  • その他

第9章 エンドユーザー別

  • 病院・クリニック
  • ウェルネスセンター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Omron Corporation
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • DoTERRA
  • Nutra Green
  • NATURAL ORGANICS INC.
  • Solaray
  • Archer Daniels Midland Company
  • Nature's Way
  • Deltastar
  • A.Vogel

第13章 付録

目次

The global phytoestrogen supplements market reached US$ 3.57 million in 2024 and is expected to reach US$ 5.11 million by 2033, growing at a CAGR of 4.6 % during the forecast period 2025-2033.

The global phytoestrogen supplements market encompasses the market for dietary supplements containing phytoestrogens plant-derived compounds that mimic estrogen in the body. These supplements are primarily used to alleviate symptoms related to hormonal changes, especially during menopause, and to support overall women's health.

The global phytoestrogen supplements market is poised for significant expansion due to increasing consumer awareness of women's health issues and the demand for natural remedies for menopause-related symptoms. With a diverse range of products available across multiple applications, this market presents numerous opportunities for manufacturers and suppliers aiming to cater to health-conscious consumers.These factors have driven the global phytoestrogen supplements market expansion.

Market Dynamics: Drivers & Restraints

Increasing Demand for Natural Alternatives to Hormone Replacement Therapy (HRT)

The increasing demand for natural alternatives to hormone replacement therapy (HRT) is a significant driver in the global phytoestrogen supplements market. This trend reflects a growing preference among consumers, particularly women experiencing menopause, for safer and more natural options to manage hormonal changes and associated symptoms.

Traditional hormone replacement therapy has been effective in alleviating menopausal symptoms, such as hot flashes and mood swings. However, it is often linked to potential health risks, including an elevated risk of breast cancer, heart disease, and blood clots. As awareness of these risks increases, many women are seeking alternatives that provide similar benefits without the associated dangers.

There is a broader societal shift towards natural and holistic health solutions. Consumers are increasingly interested in dietary supplements derived from natural sources, such as plants, which are perceived as safer and more aligned with a healthy lifestyle. Phytoestrogens, found in various plant-based foods like soy, flaxseeds, and lentils, offer a plant-derived alternative to synthetic hormones.

Furthermore, key players in the industry investments and research & developments that would drive the global phytoestrogen supplements market expansion. For instance, in October 2023, NeuTherapeutics, a startup based in Tucson, secured a $2.5 million grant from the National Institutes of Health (NIH), specifically from the National Institute on Aging (NIA). This funding will support a Phase 2 clinical trial aimed at evaluating the effectiveness of PhytoSERM, a dietary supplement designed to alleviate hot flashes in menopausal women. All these factors demand the global phytoestrogen supplements market.

Also, in December 2023, the development of PhytoSERM, a selective estrogen B-receptor phytoestrogen formulation, aims to tackle two significant health issues for women: reducing the risk of Alzheimer's disease and alleviating menopausal symptoms. This initiative is currently being explored through a Phase 2 randomized clinical trial framework. Moreover, the rising demand for the growth of growth in functional foods and beverages monitoring contributes to the global phytoestrogen supplements market expansion.

Risks of Side Effects

The risks of side effects associated with phytoestrogen supplements represent significant constraints within the global phytoestrogen supplements market. Despite their increasing popularity as natural alternatives to hormone replacement therapy (HRT), concerns about safety and potential adverse effects can undermine consumer confidence and hinder market growth.Phytoestrogens can cause various side effects, including allergic reactions, abdominal pain, muscle pain (myalgia), and sleepiness. Such adverse reactions may discourage consumers from consistently using these products, which could limit market expansion.

A meta-analysis has shown that phytoestrogen supplements are linked to moderately elevated rates of gastrointestinal side effects, such as abdominal discomfort and nausea. These issues can lead some individuals to discontinue use, creating hesitance among potential users who are concerned about their digestive health.Thus, the above factors could be limiting the global phytoestrogen supplements market's potential growth.

Segment Analysis

The global phytoestrogen supplements market is segmented based on type, source, application, end-user, and region.

Type:

The flavonoids segment is expected to dominate the global phytoestrogen supplements market share

The flavonoids segment holds a major portion of the global phytoestrogen supplements market share and is expected to continue to hold a significant portion of the global phytoestrogen supplements market share during the forecast period. The flavonoids segment within the global phytoestrogen supplements market is essential due to the unique properties and health benefits associated with flavonoids, which are a subclass of phytoestrogens. This segment is anticipated to witness significant growth as consumer awareness of the benefits of phytoestrogens increases, particularly in managing menopausal symptoms and enhancing overall health.

Flavonoids are plant-derived compounds known for their antioxidant properties and ability to mimic estrogen in the body. They can be categorized into several types, including isoflavones (such as daidzein, genistein, glycitein, and biochanin A) and coumestans. Each type has distinct biological activities and health benefits, making them valuable in dietary supplements targeted at women's health. Flavonoids are particularly recognized for their potential to alleviate menopausal symptoms, including hot flashes, mood swings, and night sweats. They also contribute to cardiovascular health, support bone density maintenance, and help achieve overall hormonal balance. This makes flavonoids appealing to women seeking natural alternatives to hormone replacement therapy (HRT).

Furthermore, key players in the industry innovative launches that would drive this segment growth in the global phytoestrogen supplements market.For instance, in November 2023, Mena, launched is a new range of products that includes breads, breakfast cereals, and snack bars specifically designed to alleviate menopause symptoms. This innovative food line incorporates ingredients rich in plant estrogens, also known as phytoestrogens, which are believed to help reduce discomfort associated with menopause. By providing these phytoestrogen-rich options, Mena offers a natural food alternative for women seeking relief during this transitional phase of life.

Also, in August 2022, Vedistry launched Fortyfitt Woman Tablets, a dietary supplement specifically designed to assist women during the transition from perimenopause to menopause. These tablets feature a potent blend of soya phytoestrogens and various nutraceuticals, including green tea, ginseng, grape seed extract, and omega-3 fatty acids. These factors have solidified the segment's position in the global phytoestrogen supplements market.

Geographical Analysis

North America is expected to hold a significant position in the global phytoestrogen supplements market share

North America holds a substantial position in the global phytoestrogen supplements market and is expected to hold most of the market share. Consumers in North America are increasingly leaning towards natural and alternative health solutions. This trend is reflected in the rising consumption of dietary supplements that contain plant-derived compounds like phytoestrogens. Concerns about the side effects associated with synthetic medications have fueled this shift towards natural ingredients.

There is a heightened awareness among women regarding menopause and its associated symptoms. As more women seek relief from symptoms such as hot flashes, mood swings, and night sweats, the demand for phytoestrogen supplements has surged. These products are increasingly viewed as effective natural alternatives to hormone replacement therapy (HRT).

There has been substantial investment in research and development within the dietary supplement industry. Companies are focusing on creating innovative phytoestrogen products that cater to health-conscious consumers. This emphasis on R&D enhances product efficacy and safety, further propelling market growth.

There is an increasing trend towards nutraceuticals foods that provide health benefits beyond basic nutrition. Phytoestrogen supplements fit well within this category as they offer specific health benefits related to hormonal balance and menopausal symptom relief.

Furthermore, in this region, a major of key players presence, well-advanced healthcare infrastructure, and launches that would drive this global phytoestrogen supplements market growth. For instance, in August 2023, Designs for Health launched a new line of women's health supplements, featuring ProbioMed Women and FemGuard-HF. These products are specifically formulated to meet the unique health requirements of women throughout various life stages. Thus, the above factors are consolidating the region's position as a dominant force in the global phytoestrogen supplements market.

Asia Pacific is growing at the fastest pace in the global phytoestrogen supplements market share

Asia Pacific holds the fastest pace in the global phytoestrogen supplements market and is expected to hold most of the market share. There has been a significant rise in health awareness among consumers in the Asia-Pacific region. Many individuals are prioritizing their health and well-being, leading to increased demand for nutritional supplements, including phytoestrogens. This shift is fueled by a growing recognition of the importance of preventive healthcare, prompting consumers to seek solutions that enhance their overall health.

The region is witnessing a rapidly aging demographic, particularly in countries like Japan and China. As more individuals enter menopause, there is heightened demand for products that address age-related health issues, including hormonal imbalances. Phytoestrogen supplements are appealing because they provide natural alternatives to hormone replacement therapy (HRT) for managing menopausal symptoms.

Consumers are increasingly favoring natural and plant-based health solutions. Many are moving away from synthetic medications due to concerns about side effects and toxicity. This trend is driving demand for phytoestrogen supplements, which are derived from natural sources and perceived as safer options. The trend toward nutraceuticals-foods that provide health benefits beyond basic nutrition is gaining traction in the Asia-Pacific market. Phytoestrogens fit well within this category, offering specific benefits related to hormonal balance and relief from menopausal symptoms, thus appealing to health-conscious consumers.

Furthermore, in this region, a major of key players presence, well-advanced healthcare infrastructure, and launches that would drive this global phytoestrogen supplements market growth. For instance, in August 2022, Charak Pharma launched Fortyfitt Woman tablets, a dietary supplement specifically formulated to assist women during their transition from perimenopause to menopause. These tablets feature a potent blend of soya phytoestrogens and various nutraceuticals, including green tea, ginseng, grape seed extract, and omega-3 fatty acids. This combination aims to support overall health and well-being for women in their forties, addressing common menopausal symptoms effectively. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global phytoestrogen supplements market.

Competitive Landscape

The major global players in the phytoestrogen supplements market include DoTERRA, Nutra Green, NATURAL ORGANICS INC., Solaray, Archer Daniels Midland Company, Nature's Way Deltastar, and A.Vogel among others.

Key Developments

  • In August 2024, Life Extension introduced the Estrogen Balance Elite supplement. A recent survey conducted by the brand revealed that over 80% of women reported experiencing hormone-related discomfort at least once a week. This statistic highlights the commonality of issues such as hot flashes, night sweats, and mood swings, particularly during perimenopause and menopause.
  • In October 2022, PharmaLinea introduced an advanced whole-body menopause supplement named Your Meno Ease. This product is specifically formulated to alleviate a variety of symptoms associated with menopause, including pain, hot flashes, and mood swings. Clinical research has shown that Your Meno Ease can reduce pain intensity by 27% compared to a placebo, highlighting its effectiveness in managing menopausal symptoms.
  • In October 2022, Health & Her introduced a new line of menopause supplements that are specifically phytoestrogen-free, catering to women who wish to avoid plant-based estrogens in their dietary products. This decision addresses the growing awareness and concerns among women regarding hormone-related issues during menopause.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global phytoestrogen supplements market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Source
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Natural Alternatives to Hormone Replacement Therapy (HRT)
    • 4.1.2. Restraints
      • 4.1.2.1. Risks of Side Effects
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Flavonoids*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Daidzein
    • 6.2.4. Genistein
    • 6.2.5. Glycitein
    • 6.2.6. Biochanin A
    • 6.2.7. Coumestans
    • 6.2.8. Prenyl Flavonoids
  • 6.3. Lignans
  • 6.4. Stilbenes
  • 6.5. Others

7. By Source

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 7.1.2. Market Attractiveness Index, By Source
  • 7.2. Soy Extract*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Nuts & Oilseeds
  • 7.4. Cereals & Bread
  • 7.5. Legumes
  • 7.6. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Food & Beverages*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Nutraceuticals
  • 8.4. Cosmetics
  • 8.5. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Wellness Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Omron Corporation *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. DoTERRA
  • 12.3. Nutra Green
  • 12.4. NATURAL ORGANICS INC.
  • 12.5. Solaray
  • 12.6. Archer Daniels Midland Company
  • 12.7. Nature's Way
  • 12.8. Deltastar
  • 12.9. A.Vogel

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us